Regeneron Pharmaceuticals purchased shares in a concurrent private placement, with Leerink Partners serving as part of the underwriting syndicate.
1 report, 1 independent
Updated Jun 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regeneron Pharmaceuticals purchased shares in a concurrent private placement, with Leerink Partners serving as part of the underwriting syndicate.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regeneron Pharmaceuticals
American pharmaceutical company
-
Leerink partners
U.S. investment bank